| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bioactive angiotensin peptides: focus on angiotensin IV
|
Mustafa, Tomris
|
|
2001
|
2 |
4 |
p. 205-210
|
artikel
|
| 2 |
Effects of candesartan on cardiac and arterial structure and function in hypertensive subjects
|
Spratt, James CS
|
|
2001
|
2 |
4 |
p. 227-232
|
artikel
|
| 3 |
Evaluation of the safety and efficacy of telmisartan and enalapril, with the potential addition of frusemide, in moderate-renal failure patients with mild-to-moderate hypertension
|
Hannedouche, Thierry
|
|
2001
|
2 |
4 |
p. 246-254
|
artikel
|
| 4 |
High serum enalaprilat in chronic renal failure
|
Elung-Jensen, Thomas
|
|
2001
|
2 |
4 |
p. 240-245
|
artikel
|
| 5 |
Losartan may modulate erythropoietin production
|
Donnelly, Sandra M
|
|
2001
|
2 |
4 |
p. 255-260
|
artikel
|
| 6 |
Renin-angiotensin blockade improves renal cGMP production via non-AT2-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat
|
Uhlenius, Nina
|
|
2001
|
2 |
4 |
p. 233-239
|
artikel
|
| 7 |
Review: Aldosterone-induced vasculopathy: a new reversible cause of cardiac death
|
Struthers, Allan D
|
|
2001
|
2 |
4 |
p. 211-214
|
artikel
|
| 8 |
Review: Intracellular angiotensin II: from myth to reality?
|
Filipeanu, Catalin M
|
|
2001
|
2 |
4 |
p. 219-226
|
artikel
|
| 9 |
Review: Prospects for ARB in the next five years
|
Skali, Hicham
|
|
2001
|
2 |
4 |
p. 215-218
|
artikel
|
Tijdschrift beschrijving